Status:

COMPLETED

Study to Assess Colonic Microbiota Changes in Response to Energy Drink Consumption

Lead Sponsor:

University of Florida

Collaborating Sponsors:

McJunkin Family Charitable Foundation

Conditions:

Colorectal Cancer

Eligibility:

All Genders

18-40 years

Phase:

PHASE2

Brief Summary

This study will investigate whether short-term daily energy drink consumption results in an increase in hydrogen sulfide-producing bacteria in adults 18-40 years old.

Detailed Description

Colorectal cancer (CRC) is the 2nd leading cause of cancer deaths in the US. The bulk of new diagnoses typically occurs after the age of 50 for those without personal or family histories of this disea...

Eligibility Criteria

Inclusion

  • Adults ≥ 18 years of age AND ≤ 40 years of age
  • Written informed consent obtained from the subject and the subject agrees to comply with all the study-related procedures
  • Subject willing to complete/comply with study required specimen and survey assessments
  • Current energy drink consumption of ≤2 energy drinks weekly
  • Written informed consent obtained from the subject to participate in two companion biobanks: 1) Dr. Thomas George's Tumor and Biospecimen Sample Biobank and 2) Dr. Ryan Thomas's Microbiorepository for future research.

Exclusion

  • Personal history of colorectal cancer (CRC)
  • Inflammatory Bowel Disease (IBD)
  • Chronic diarrhea or other chronic gastrointestinal (GI) problems felt to interfere with study conduct per the PI
  • Regular (daily) intake of probiotics
  • Oral or IV antibiotic use within the past 28 days (prior to intervention start date)
  • Known intolerance of or sensitivity to caffeine
  • Prisoners or subjects who are involuntarily incarcerated, or subjects who are compulsorily detained for treatment of either a psychiatric or physical illness.
  • Known pregnancy at the time of enrollment

Key Trial Info

Start Date :

February 28 2024

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

April 17 2025

Estimated Enrollment :

76 Patients enrolled

Trial Details

Trial ID

NCT06137248

Start Date

February 28 2024

End Date

April 17 2025

Last Update

May 6 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Florida

Gainesville, Florida, United States, 32608